Relating to the use of epinephrine auto-injectors on public school and open-enrollment charter school campuses and at or in transit to or from off-campus school events.
Impact
The legislation mandates that each school district and open-enrollment charter school adopt policies related to the maintenance, administration, and proper disposal of epinephrine auto-injectors. This act will considerably impact school health policies, emphasizing the importance of having trained personnel on-site to manage potential instances of anaphylaxis. Furthermore, it outlines the establishment of an advisory committee that includes physicians and nursing professionals to oversee implementation and ensure compliance with training and administration protocols.
Summary
SB66, titled the Cameron Espinosa Act, focuses on the use and management of epinephrine auto-injectors in public and charter schools within Texas. It establishes protocols for training school personnel to administer these auto-injectors effectively, ensuring preparedness for cases of anaphylaxis — a severe allergic reaction. The bill aims to create a safe environment for students at school campuses and while involved in off-campus events by enabling immediate response to allergic emergencies through readily available epinephrine auto-injectors.
Sentiment
Overall, the sentiment surrounding SB66 appears positive, with support focusing on enhancing student safety and health responsiveness within educational settings. School districts and health officials generally advocate for the bill, perceiving it as a crucial step towards better health management in schools. However, concerns may arise around the logistics of training, resource allocation, and maintaining an adequate supply of epinephrine auto-injectors.
Contention
While the bill is largely supported, some opposition may concern the financial implications of stocking epinephrine auto-injectors and the requirement for training personnel, as it could impose additional responsibilities on schools already facing budget constraints. Critics may also argue regarding the adequacy of state-funding provisions and the training effectiveness. Nonetheless, the bill underscores the necessity for protective measures to address life-threatening allergic reactions among students.
Identical
Relating to the use of epinephrine auto-injectors on public and open-enrollment charter school campuses and at off-campus school-sanctioned events.
TX HB2847
Relating to policies and training regarding the use of epinephrine auto-injectors by school districts and open-enrollment charter schools; providing immunity.
Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
Relating to the use of epinephrine auto-injectors and medication designated for treatment of respiratory distress on public and private school campuses.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the establishment of a grant program for school districts or open-enrollment charter school campuses that are designated as full-service community schools.
Relating to the establishment of a grant program for school districts or open-enrollment charter school campuses that are designated as full-service community schools.
Relating to the establishment of a grant program for school districts or open-enrollment charter school campuses that are designated as full-service community schools.
Relating to policies and training regarding the use of epinephrine auto-injectors by school districts and open-enrollment charter schools; providing immunity.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.